Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.
Press releases published on April 10, 2025
Nextech and Ocuco Announce Strategic Partnership to Revolutionize Optical Solutions
GlobeNewswire
·
April 10, 2025
Tampa, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- Nextech, a leading technology provider for specialty medical and wellness practices and Ocuco, a global leader in optical software solutions, are excited to announce a strategic partnership to deliver an …
Eleos Expands Executive Leadership Bench Following Series C Fundraise
GlobeNewswire
·
April 10, 2025
BOSTON and TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Eleos, the leader in AI for behavioral health, today announced the appointment of a deep bench of industry-leading executive talent to support the company through its next phase of growth. …
Elixir Medical Announces Launch of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Europe
GlobeNewswire
·
April 10, 2025
Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified coronary artery lesions without requiring an energy source. IVL technology expands company’s innovative product portfolio. MILPITAS, Calif., …
Over 53 Million Myeloma Milestones Shared During 2025 Myeloma Action Month
GlobeNewswire
·
April 10, 2025
STUDIO CITY, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- At the conclusion of this year’s Myeloma Action Month, the International Myeloma Foundation (IMF) was truly grateful and overwhelmed by everyone’s support in making the annual campaign a global …
Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.
GlobeNewswire
·
April 10, 2025
Industry leader in the development and application of cellular therapies, including CAR NK products, for cancer Led development of multiple clinical candidates from conception through IND and early clinical development Vast experience in technology …
US Ultrasound Market worth US$3.82 billion by 2030 with 7.6% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 10, 2025
Delray Beach, FL, April 10, 2025 (GLOBE NEWSWIRE) -- The US Ultrasound Market is projected to reach US$3.82 billion by 2030 from US$2.46 billion in 2024, at a CAGR of 7.6%. The US ultrasound market is growing due to AI-integrated ultrasound imaging …
Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency
GlobeNewswire
·
April 10, 2025
- Data from the largest retrospective analysis of ENPP1 Deficiency provides insights into the evolution of the disease’s serious cardiovascular and musculoskeletal complications - - Findings highlight the urgent need for early and improved diagnosis, care …
Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder
GlobeNewswire
·
April 10, 2025
Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
VitalHub Announces Recommended Cash Acquisition of Induction Healthcare Group PLC
GlobeNewswire
·
April 10, 2025
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) is pleased to announce that it has agreed the terms and conditions of a recommended cash acquisition to acquire all of the issued and to be …
Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema
GlobeNewswire
·
April 10, 2025
DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading record speed across 119 sites …
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
GlobeNewswire
·
April 10, 2025
ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need …
Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis
GlobeNewswire
·
April 10, 2025
– Patient-reported outcomes from Phase 2 trial of oxylanthanum carbonate (OLC) demonstrate high patient satisfaction with OLC compared to their prior phosphate lowering therapy – – Findings from a patient survey conducted in partnership with the National …
Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors
GlobeNewswire
·
April 10, 2025
Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company’s commitment to advancing Jankistomig, a one-of-a-kind PD-1/VEGFR2 dual paratopic …
Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
GlobeNewswire
·
April 10, 2025
Advanced BVA System Designed for Faster, Simpler Bedside Testing Oak Ridge, TN, April 10, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), a leader in blood volume measurement technology, announces today the submission of its next-generation blood …
Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China
GlobeNewswire
·
April 10, 2025
FREEHOLD, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, announced today that it has been …
Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders
GlobeNewswire
·
April 10, 2025
A$5.0 million commitment received from Australian-based private investor A$10.8 million Entitlement Offer at the same offer price as the placement Funds to support Phase III Topical clinical trials in Indonesia and Australia – catalysts for revenue in 2026 …
Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025
GlobeNewswire
·
April 10, 2025
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, April 10, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, …
Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting
GlobeNewswire
·
April 10, 2025
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an event and …
Large Reductions in Suicide Risk, Attempts and Deaths Demonstrated by Three “Real World” Studies in Primary Care
GlobeNewswire
·
April 10, 2025
NORWALK, Conn., April 10, 2025 (GLOBE NEWSWIRE) -- The suicide rate in the US was at a more than 80-year high in 2022 with a leveling at this higher rate in the past three years. And a large majority of patients who die by suicide have visited a primary …
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
GlobeNewswire
·
April 10, 2025
– SRC recommended that the trial escalate to the next dose level of 30mg capsule – – No dose-limiting toxicities (DLT’s) or rash observed to date – MIAMI, April 10, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “ …